Simplera

Verify with FDA CVM →

13 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
13
Total Reports
1
Deaths Reported
770.0%
Death Rate

Active Ingredients

Simplera

Administration Routes

Auricular (Otic)UnknownTopical

Species Affected

Dog 13

Most Affected Breeds

Bulldog - French 3
Retriever - Labrador 2
Boxer (German Boxer) 1
Shih Tzu 1
Spaniel - Boykin 1
Poodle (unspecified) 1
Shepherd (unspecified) 1
Crossbred Canine/dog 1
Shepherd Dog - Australian 1
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 1

Most Reported Reactions

Seizure NOS 4
Diarrhoea 3
Other abnormal test result NOS 2
Emesis (multiple) 2
Vomiting 2
Drooling 2
Panting 2
Shaking 2
Falling 2
Abnormal menace reflex test 2
Impaired proprioception 2
Lumbar pain 2

Outcome Breakdown

Ongoing
9 (69.2%)
Outcome Unknown
2 (15.4%)
Euthanized
1 (7.7%)
Recovered/Normal
1 (7.7%)

Data Summary

Metric Value
Total adverse event reports 13
Reports involving death 1
Case-fatality rate (reported events) 770.0%
Distinct species in reports 1
Distinct breeds in reports 10
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Simplera Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 13 adverse event reports referencing Simplera, including 1 reports in which the animal died — a 770.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Simplera. Reported administration routes include Auricular (Otic), Unknown, Topical. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Simplera reports are Dog (13 reports), with Dog accounting for the largest share. Within those species, Bulldog - French (3), Retriever - Labrador (2), Boxer (German Boxer) (1) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Simplera are Seizure NOS (4), Diarrhoea (3), Other abnormal test result NOS (2), Emesis (multiple) (2). Of the 13 reports with a coded outcome, Ongoing is the leading category at 69.2%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Simplera.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial